

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein localization to endosome (GO:0036010) | 4.74237102 |
| 2 | barbed-end actin filament capping (GO:0051016) | 3.99824899 |
| 3 | low-density lipoprotein particle clearance (GO:0034383) | 3.91280233 |
| 4 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.86559901 |
| 5 | response to peptidoglycan (GO:0032494) | 3.76296918 |
| 6 | pinocytosis (GO:0006907) | 3.51616849 |
| 7 | Golgi transport vesicle coating (GO:0048200) | 3.49465765 |
| 8 | COPI coating of Golgi vesicle (GO:0048205) | 3.49465765 |
| 9 | apoptotic cell clearance (GO:0043277) | 3.44488458 |
| 10 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.38345697 |
| 11 | pentose-phosphate shunt (GO:0006098) | 3.35991929 |
| 12 | cortical actin cytoskeleton organization (GO:0030866) | 3.30938524 |
| 13 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.28425280 |
| 14 | negative regulation of cell killing (GO:0031342) | 3.28425280 |
| 15 | positive regulation of histone deacetylation (GO:0031065) | 3.26796192 |
| 16 | response to laminar fluid shear stress (GO:0034616) | 3.25514085 |
| 17 | NADPH regeneration (GO:0006740) | 3.21784699 |
| 18 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.19678313 |
| 19 | regulation of cholesterol homeostasis (GO:2000188) | 3.14449318 |
| 20 | regulation of cholesterol storage (GO:0010885) | 3.14346090 |
| 21 | cysteine metabolic process (GO:0006534) | 3.13070797 |
| 22 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.12855858 |
| 23 | neutrophil activation involved in immune response (GO:0002283) | 3.10332797 |
| 24 | positive regulation by symbiont of host defense response (GO:0052509) | 3.07827228 |
| 25 | modulation by symbiont of host defense response (GO:0052031) | 3.07827228 |
| 26 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.07827228 |
| 27 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.07827228 |
| 28 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.07827228 |
| 29 | modulation by symbiont of host immune response (GO:0052553) | 3.07827228 |
| 30 | regulation of leukocyte degranulation (GO:0043300) | 3.02658634 |
| 31 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.01587304 |
| 32 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.01587304 |
| 33 | negative regulation of interleukin-12 production (GO:0032695) | 3.01339347 |
| 34 | glycosphingolipid catabolic process (GO:0046479) | 3.00812643 |
| 35 | macrophage activation involved in immune response (GO:0002281) | 2.99935376 |
| 36 | alpha-linolenic acid metabolic process (GO:0036109) | 2.94300764 |
| 37 | lysine metabolic process (GO:0006553) | 2.92018621 |
| 38 | lysine catabolic process (GO:0006554) | 2.92018621 |
| 39 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.91591831 |
| 40 | regulation of mast cell degranulation (GO:0043304) | 2.87532743 |
| 41 | cell adhesion mediated by integrin (GO:0033627) | 2.87030744 |
| 42 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.86761654 |
| 43 | cortical cytoskeleton organization (GO:0030865) | 2.85999307 |
| 44 | regulation of early endosome to late endosome transport (GO:2000641) | 2.83876189 |
| 45 | NIK/NF-kappaB signaling (GO:0038061) | 2.82216041 |
| 46 | skin morphogenesis (GO:0043589) | 2.81415336 |
| 47 | maternal placenta development (GO:0001893) | 2.79689107 |
| 48 | adhesion of symbiont to host cell (GO:0044650) | 2.77248208 |
| 49 | virion attachment to host cell (GO:0019062) | 2.77248208 |
| 50 | positive regulation of p38MAPK cascade (GO:1900745) | 2.75817792 |
| 51 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.75535947 |
| 52 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.75329760 |
| 53 | detection of other organism (GO:0098543) | 2.74987782 |
| 54 | plasma lipoprotein particle clearance (GO:0034381) | 2.74941886 |
| 55 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.73625312 |
| 56 | protein retention in ER lumen (GO:0006621) | 2.72609109 |
| 57 | regulation of defense response to virus by virus (GO:0050690) | 2.72327907 |
| 58 | cell-substrate junction assembly (GO:0007044) | 2.71774839 |
| 59 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.71479169 |
| 60 | regulation of p38MAPK cascade (GO:1900744) | 2.70126578 |
| 61 | adhesion of symbiont to host (GO:0044406) | 2.69929653 |
| 62 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.68260227 |
| 63 | modulation by symbiont of host cellular process (GO:0044068) | 2.68146254 |
| 64 | glycolipid catabolic process (GO:0019377) | 2.66440472 |
| 65 | response to muramyl dipeptide (GO:0032495) | 2.66213860 |
| 66 | immunoglobulin mediated immune response (GO:0016064) | 2.66132812 |
| 67 | detection of molecule of bacterial origin (GO:0032490) | 2.64725272 |
| 68 | positive regulation of Rho protein signal transduction (GO:0035025) | 2.63599032 |
| 69 | stress fiber assembly (GO:0043149) | 2.63511428 |
| 70 | regulation of superoxide anion generation (GO:0032928) | 2.63251369 |
| 71 | amino sugar catabolic process (GO:0046348) | 2.61877743 |
| 72 | detection of bacterium (GO:0016045) | 2.60699506 |
| 73 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.60383976 |
| 74 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.59033902 |
| 75 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.57166647 |
| 76 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.56603596 |
| 77 | detection of external biotic stimulus (GO:0098581) | 2.54736657 |
| 78 | regulation of extracellular matrix disassembly (GO:0010715) | 2.54206579 |
| 79 | receptor catabolic process (GO:0032801) | 2.53444995 |
| 80 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.52220485 |
| 81 | semaphorin-plexin signaling pathway (GO:0071526) | 2.52148855 |
| 82 | positive regulation of leukocyte degranulation (GO:0043302) | 2.51820336 |
| 83 | basement membrane organization (GO:0071711) | 2.50441851 |
| 84 | adherens junction assembly (GO:0034333) | 2.50406398 |
| 85 | positive regulation of extracellular matrix organization (GO:1903055) | 2.48503199 |
| 86 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.47310227 |
| 87 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.46524626 |
| 88 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.46432058 |
| 89 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.46409600 |
| 90 | L-phenylalanine metabolic process (GO:0006558) | 2.46409600 |
| 91 | response to thyroid hormone (GO:0097066) | 2.45893607 |
| 92 | hyaluronan catabolic process (GO:0030214) | 2.45654347 |
| 93 | sulfur amino acid catabolic process (GO:0000098) | 2.45322094 |
| 94 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.42065827 |
| 95 | regulation of regulated secretory pathway (GO:1903305) | 2.41585333 |
| 96 | glyoxylate metabolic process (GO:0046487) | 2.41065857 |
| 97 | cell-substrate adherens junction assembly (GO:0007045) | 2.41045284 |
| 98 | focal adhesion assembly (GO:0048041) | 2.41045284 |
| 99 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.41009742 |
| 100 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.40980509 |
| 101 | NADP metabolic process (GO:0006739) | 2.40557096 |
| 102 | growth hormone receptor signaling pathway (GO:0060396) | 2.38965185 |
| 103 | negative regulation of cell size (GO:0045792) | 2.38772197 |
| 104 | myeloid dendritic cell differentiation (GO:0043011) | 2.37125454 |
| 105 | response to host defenses (GO:0052200) | 2.36013596 |
| 106 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.36013596 |
| 107 | response to host (GO:0075136) | 2.36013596 |
| 108 | drug transmembrane transport (GO:0006855) | 2.35370420 |
| 109 | myelin maintenance (GO:0043217) | 2.35215261 |
| 110 | endocytic recycling (GO:0032456) | 2.35137221 |
| 111 | modulation by virus of host process (GO:0019054) | 2.33843877 |
| 112 | oligosaccharide catabolic process (GO:0009313) | 2.33207939 |
| 113 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.32890701 |
| 114 | positive regulation of receptor recycling (GO:0001921) | 2.32602557 |
| 115 | L-phenylalanine catabolic process (GO:0006559) | 2.32317915 |
| 116 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.32317915 |
| 117 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.32240055 |
| 118 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.31167444 |
| 119 | response to host immune response (GO:0052572) | 2.30439512 |
| 120 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.30439512 |
| 121 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.29947185 |
| 122 | urate metabolic process (GO:0046415) | 2.28582075 |
| 123 | germ cell migration (GO:0008354) | 2.27895696 |
| 124 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.26940249 |
| 125 | 4-hydroxyproline metabolic process (GO:0019471) | 2.26689866 |
| 126 | detection of biotic stimulus (GO:0009595) | 2.26608971 |
| 127 | cellular modified amino acid catabolic process (GO:0042219) | 2.25949130 |
| 128 | mannose metabolic process (GO:0006013) | 2.25817657 |
| 129 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.25225440 |
| 130 | germinal center formation (GO:0002467) | 2.25040994 |
| 131 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.24972793 |
| 132 | hemidesmosome assembly (GO:0031581) | 2.24916188 |
| 133 | glutamate metabolic process (GO:0006536) | 2.24314980 |
| 134 | response to growth hormone (GO:0060416) | 2.23907140 |
| 135 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.23189776 |
| 136 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.22647031 |
| 137 | protein carboxylation (GO:0018214) | 2.21668613 |
| 138 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.21668613 |
| 139 | cellular response to type I interferon (GO:0071357) | 2.21037995 |
| 140 | type I interferon signaling pathway (GO:0060337) | 2.21037995 |
| 141 | granulocyte activation (GO:0036230) | 2.19721440 |
| 142 | apoptotic process involved in morphogenesis (GO:0060561) | 2.19305140 |
| 143 | embryonic process involved in female pregnancy (GO:0060136) | 2.19068725 |
| 144 | glucose 6-phosphate metabolic process (GO:0051156) | 2.18602880 |
| 145 | negative regulation of cholesterol transport (GO:0032375) | 2.18223646 |
| 146 | negative regulation of sterol transport (GO:0032372) | 2.18223646 |
| 147 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.17869647 |
| 148 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.17309290 |
| 149 | response to type I interferon (GO:0034340) | 2.17128437 |
| 150 | response to fluid shear stress (GO:0034405) | 2.17074952 |
| 151 | negative regulation of fibrinolysis (GO:0051918) | 2.16514536 |
| 152 | cellular response to arsenic-containing substance (GO:0071243) | 2.16122631 |
| 153 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.16028134 |
| 154 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.15957789 |
| 155 | regulation of macrophage cytokine production (GO:0010935) | 2.14541563 |
| 156 | regulation of ARF GTPase activity (GO:0032312) | 2.14082517 |
| 157 | sodium ion export (GO:0071436) | 2.13650004 |
| 158 | negative regulation of lipid transport (GO:0032369) | 2.13403084 |
| 159 | response to mercury ion (GO:0046689) | 2.13334632 |
| 160 | respiratory burst (GO:0045730) | 2.12311953 |
| 161 | aspartate family amino acid catabolic process (GO:0009068) | 2.09899035 |
| 162 | amyloid precursor protein catabolic process (GO:0042987) | 2.09829482 |
| 163 | glucose catabolic process (GO:0006007) | 2.08642360 |
| 164 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.08581063 |
| 165 | protein-lipid complex assembly (GO:0065005) | 2.07965975 |
| 166 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.07619408 |
| 167 | cellular response to growth hormone stimulus (GO:0071378) | 2.07368314 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.02453401 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.46504532 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.20718895 |
| 4 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.09291016 |
| 5 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.80526319 |
| 6 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.70596765 |
| 7 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.56531076 |
| 8 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.54686038 |
| 9 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.51954314 |
| 10 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.36884566 |
| 11 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.29985857 |
| 12 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.29538572 |
| 13 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.26425154 |
| 14 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.25714496 |
| 15 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.23901322 |
| 16 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.17904814 |
| 17 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.14640361 |
| 18 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.14634792 |
| 19 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.12101010 |
| 20 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.11105750 |
| 21 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.07176354 |
| 22 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.94936851 |
| 23 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.93255262 |
| 24 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.93222026 |
| 25 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.87704700 |
| 26 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.87683649 |
| 27 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.85883753 |
| 28 | MYC_22102868_ChIP-Seq_BL_Human | 1.79393981 |
| 29 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.77996088 |
| 30 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.71148186 |
| 31 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.70935839 |
| 32 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.66431621 |
| 33 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.66032918 |
| 34 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.65370916 |
| 35 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.64840588 |
| 36 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62496486 |
| 37 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.61216141 |
| 38 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.61167145 |
| 39 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.60919019 |
| 40 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.60136513 |
| 41 | KDM2B_26808549_Chip-Seq_K562_Human | 1.57673316 |
| 42 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.54967590 |
| 43 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.54744298 |
| 44 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.54498367 |
| 45 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.52048970 |
| 46 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.48532931 |
| 47 | MAF_26560356_Chip-Seq_TH1_Human | 1.48481631 |
| 48 | ATF3_27146783_Chip-Seq_COLON_Human | 1.48398956 |
| 49 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.47927747 |
| 50 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.45127680 |
| 51 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.45064332 |
| 52 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.44792673 |
| 53 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.43061952 |
| 54 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.42591418 |
| 55 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.42220655 |
| 56 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.39773085 |
| 57 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.36540483 |
| 58 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.35958069 |
| 59 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.35220353 |
| 60 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.34497004 |
| 61 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.34218109 |
| 62 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.33810938 |
| 63 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.31924257 |
| 64 | UTX_26944678_Chip-Seq_JUKART_Human | 1.31709584 |
| 65 | GATA1_19941826_ChIP-Seq_K562_Human | 1.31204038 |
| 66 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.27319960 |
| 67 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.25584191 |
| 68 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.24783872 |
| 69 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.24253754 |
| 70 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.23414172 |
| 71 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.23133584 |
| 72 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22894424 |
| 73 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.22669000 |
| 74 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.22401194 |
| 75 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.21370898 |
| 76 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.20767821 |
| 77 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.20740371 |
| 78 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.20666015 |
| 79 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.20485825 |
| 80 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.18767200 |
| 81 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.18689748 |
| 82 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18509960 |
| 83 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18332099 |
| 84 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.17667587 |
| 85 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.17290829 |
| 86 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.16777279 |
| 87 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.12680453 |
| 88 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.12402830 |
| 89 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.12179028 |
| 90 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.12086920 |
| 91 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.10439835 |
| 92 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.10429123 |
| 93 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.10191984 |
| 94 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.09577891 |
| 95 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.08990541 |
| 96 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08549621 |
| 97 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.08450359 |
| 98 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.07785908 |
| 99 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.06738958 |
| 100 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.06302321 |
| 101 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.06263170 |
| 102 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.06156401 |
| 103 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06065122 |
| 104 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.05262704 |
| 105 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.05016201 |
| 106 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.04160349 |
| 107 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.03767558 |
| 108 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03079309 |
| 109 | GATA2_19941826_ChIP-Seq_K562_Human | 1.02505829 |
| 110 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.02387577 |
| 111 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.02195143 |
| 112 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.02167953 |
| 113 | MAF_26560356_Chip-Seq_TH2_Human | 1.01759905 |
| 114 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.99258641 |
| 115 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.98943824 |
| 116 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.98589071 |
| 117 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.98489777 |
| 118 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.98390224 |
| 119 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.96767318 |
| 120 | * SPI1_23127762_ChIP-Seq_K562_Human | 0.96750281 |
| 121 | P68_20966046_ChIP-Seq_HELA_Human | 0.96733747 |
| 122 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96088502 |
| 123 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.94573270 |
| 124 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.94433005 |
| 125 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.94433005 |
| 126 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.93547453 |
| 127 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.92714315 |
| 128 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.92655028 |
| 129 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.92481103 |
| 130 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.91461226 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003705_abnormal_hypodermis_morpholog | 4.83723435 |
| 2 | MP0003303_peritoneal_inflammation | 3.47409462 |
| 3 | MP0003300_gastrointestinal_ulcer | 3.38685560 |
| 4 | MP0005360_urolithiasis | 3.32846668 |
| 5 | MP0009840_abnormal_foam_cell | 3.15634851 |
| 6 | MP0008438_abnormal_cutaneous_collagen | 2.81094052 |
| 7 | MP0005451_abnormal_body_composition | 2.74313445 |
| 8 | MP0005058_abnormal_lysosome_morphology | 2.71560034 |
| 9 | MP0002139_abnormal_hepatobiliary_system | 2.56497881 |
| 10 | MP0004185_abnormal_adipocyte_glucose | 2.49376856 |
| 11 | MP0003724_increased_susceptibility_to | 2.30444226 |
| 12 | MP0003191_abnormal_cellular_cholesterol | 2.25779469 |
| 13 | MP0008260_abnormal_autophagy | 2.23286841 |
| 14 | MP0003566_abnormal_cell_adhesion | 2.10914024 |
| 15 | MP0010234_abnormal_vibrissa_follicle | 2.08463113 |
| 16 | MP0003172_abnormal_lysosome_physiology | 2.02272043 |
| 17 | MP0010352_gastrointestinal_tract_polyps | 1.97356071 |
| 18 | MP0001835_abnormal_antigen_presentation | 1.96103508 |
| 19 | MP0005025_abnormal_response_to | 1.91322498 |
| 20 | MP0001958_emphysema | 1.80639945 |
| 21 | MP0002148_abnormal_hypersensitivity_rea | 1.80239102 |
| 22 | MP0000604_amyloidosis | 1.77626696 |
| 23 | MP0009785_altered_susceptibility_to | 1.75984600 |
| 24 | MP0002138_abnormal_hepatobiliary_system | 1.69131345 |
| 25 | MP0002877_abnormal_melanocyte_morpholog | 1.65833922 |
| 26 | MP0002796_impaired_skin_barrier | 1.64333340 |
| 27 | MP0003329_amyloid_beta_deposits | 1.62843899 |
| 28 | MP0003453_abnormal_keratinocyte_physiol | 1.62842892 |
| 29 | MP0006082_CNS_inflammation | 1.61659651 |
| 30 | MP0003690_abnormal_glial_cell | 1.61563040 |
| 31 | MP0003279_aneurysm | 1.58042104 |
| 32 | MP0005076_abnormal_cell_differentiation | 1.57303201 |
| 33 | MP0009333_abnormal_splenocyte_physiolog | 1.57137793 |
| 34 | MP0005083_abnormal_biliary_tract | 1.55955940 |
| 35 | MP0009278_abnormal_bone_marrow | 1.55694769 |
| 36 | MP0004947_skin_inflammation | 1.52485688 |
| 37 | MP0005023_abnormal_wound_healing | 1.48882733 |
| 38 | MP0003436_decreased_susceptibility_to | 1.47592875 |
| 39 | MP0004510_myositis | 1.43131593 |
| 40 | MP0003075_altered_response_to | 1.43005946 |
| 41 | MP0005623_abnormal_meninges_morphology | 1.42378289 |
| 42 | MP0004858_abnormal_nervous_system | 1.42322927 |
| 43 | MP0002452_abnormal_antigen_presenting | 1.41812706 |
| 44 | MP0010329_abnormal_lipoprotein_level | 1.40716634 |
| 45 | MP0002723_abnormal_immune_serum | 1.39860764 |
| 46 | MP0003252_abnormal_bile_duct | 1.38606675 |
| 47 | MP0005666_abnormal_adipose_tissue | 1.37849553 |
| 48 | MP0005332_abnormal_amino_acid | 1.37053826 |
| 49 | MP0001849_ear_inflammation | 1.35045786 |
| 50 | MP0010155_abnormal_intestine_physiology | 1.32854209 |
| 51 | MP0002420_abnormal_adaptive_immunity | 1.32170536 |
| 52 | MP0001819_abnormal_immune_cell | 1.32101362 |
| 53 | MP0005275_abnormal_skin_tensile | 1.31878646 |
| 54 | MP0009643_abnormal_urine_homeostasis | 1.30397207 |
| 55 | MP0000733_abnormal_muscle_development | 1.27248641 |
| 56 | MP0008875_abnormal_xenobiotic_pharmacok | 1.27121981 |
| 57 | MP0003091_abnormal_cell_migration | 1.25001157 |
| 58 | MP0003828_pulmonary_edema | 1.24836271 |
| 59 | MP0001853_heart_inflammation | 1.24389709 |
| 60 | MP0008961_abnormal_basal_metabolism | 1.24129661 |
| 61 | MP0002254_reproductive_system_inflammat | 1.24034996 |
| 62 | MP0001800_abnormal_humoral_immune | 1.23093017 |
| 63 | MP0003183_abnormal_peptide_metabolism | 1.22173107 |
| 64 | MP0000609_abnormal_liver_physiology | 1.21425446 |
| 65 | MP0005375_adipose_tissue_phenotype | 1.20078191 |
| 66 | MP0003656_abnormal_erythrocyte_physiolo | 1.19998809 |
| 67 | MP0005671_abnormal_response_to | 1.19762066 |
| 68 | MP0004272_abnormal_basement_membrane | 1.18713750 |
| 69 | MP0000920_abnormal_myelination | 1.17527009 |
| 70 | MP0005409_darkened_coat_color | 1.16955803 |
| 71 | MP0005085_abnormal_gallbladder_physiolo | 1.15747912 |
| 72 | MP0001851_eye_inflammation | 1.15487742 |
| 73 | MP0000678_abnormal_parathyroid_gland | 1.13279931 |
| 74 | MP0002405_respiratory_system_inflammati | 1.11757411 |
| 75 | MP0005390_skeleton_phenotype | 1.11690655 |
| 76 | MP0005464_abnormal_platelet_physiology | 1.11679557 |
| 77 | MP0000685_abnormal_immune_system | 1.11004934 |
| 78 | MP0003448_altered_tumor_morphology | 1.10718083 |
| 79 | MP0001533_abnormal_skeleton_physiology | 1.10334831 |
| 80 | MP0005501_abnormal_skin_physiology | 1.08388793 |
| 81 | MP0005167_abnormal_blood-brain_barrier | 1.07435813 |
| 82 | MP0002136_abnormal_kidney_physiology | 1.06006735 |
| 83 | MP0004019_abnormal_vitamin_homeostasis | 1.04069284 |
| 84 | MP0002060_abnormal_skin_morphology | 1.02756836 |
| 85 | MP0002118_abnormal_lipid_homeostasis | 1.01217966 |
| 86 | MP0009764_decreased_sensitivity_to | 0.99151179 |
| 87 | MP0000716_abnormal_immune_system | 0.95375696 |
| 88 | MP0005397_hematopoietic_system_phenotyp | 0.95161632 |
| 89 | MP0001545_abnormal_hematopoietic_system | 0.95161632 |
| 90 | MP0005165_increased_susceptibility_to | 0.93766558 |
| 91 | MP0001756_abnormal_urination | 0.93433491 |
| 92 | MP0000767_abnormal_smooth_muscle | 0.93351374 |
| 93 | MP0003763_abnormal_thymus_physiology | 0.93138730 |
| 94 | MP0010368_abnormal_lymphatic_system | 0.93041334 |
| 95 | MP0005365_abnormal_bile_salt | 0.92341658 |
| 96 | MP0005164_abnormal_response_to | 0.90977597 |
| 97 | MP0000465_gastrointestinal_hemorrhage | 0.90676505 |
| 98 | MP0004130_abnormal_muscle_cell | 0.90249624 |
| 99 | MP0001542_abnormal_bone_strength | 0.89324769 |
| 100 | MP0004233_abnormal_muscle_weight | 0.88677363 |
| 101 | MP0003045_fibrosis | 0.88510178 |
| 102 | MP0008004_abnormal_stomach_pH | 0.88040336 |
| 103 | MP0002398_abnormal_bone_marrow | 0.87246446 |
| 104 | MP0003795_abnormal_bone_structure | 0.86147876 |
| 105 | MP0005319_abnormal_enzyme/_coenzyme | 0.85058071 |
| 106 | MP0010678_abnormal_skin_adnexa | 0.84962959 |
| 107 | MP0000681_abnormal_thyroid_gland | 0.84701761 |
| 108 | MP0005257_abnormal_intraocular_pressure | 0.84542985 |
| 109 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.84445306 |
| 110 | MP0000003_abnormal_adipose_tissue | 0.83707174 |
| 111 | MP0002429_abnormal_blood_cell | 0.83705660 |
| 112 | MP0001790_abnormal_immune_system | 0.83346697 |
| 113 | MP0005387_immune_system_phenotype | 0.83346697 |
| 114 | MP0001216_abnormal_epidermal_layer | 0.81276573 |
| 115 | MP0005166_decreased_susceptibility_to | 0.80573700 |
| 116 | MP0000343_altered_response_to | 0.80390843 |
| 117 | MP0002419_abnormal_innate_immunity | 0.80072511 |
| 118 | MP0000467_abnormal_esophagus_morphology | 0.79830328 |
| 119 | MP0000249_abnormal_blood_vessel | 0.79177840 |
| 120 | MP0001666_abnormal_nutrient_absorption | 0.78773912 |
| 121 | MP0002998_abnormal_bone_remodeling | 0.78440550 |
| 122 | MP0001915_intracranial_hemorrhage | 0.78407006 |
| 123 | MP0000490_abnormal_crypts_of | 0.78256412 |
| 124 | MP0003866_abnormal_defecation | 0.77877193 |
| 125 | MP0001348_abnormal_lacrimal_gland | 0.77658063 |
| 126 | MP0002971_abnormal_brown_adipose | 0.75537708 |
| 127 | MP0000377_abnormal_hair_follicle | 0.75508056 |
| 128 | MP0002722_abnormal_immune_system | 0.75062810 |
| 129 | MP0002933_joint_inflammation | 0.74830095 |
| 130 | MP0009384_cardiac_valve_regurgitation | 0.74719934 |
| 131 | MP0008874_decreased_physiological_sensi | 0.73680688 |
| 132 | MP0002168_other_aberrant_phenotype | 0.73561858 |
| 133 | MP0000858_altered_metastatic_potential | 0.73543638 |
| 134 | MP0009931_abnormal_skin_appearance | 0.73531458 |
| 135 | MP0003634_abnormal_glial_cell | 0.72297537 |
| 136 | MP0004883_abnormal_blood_vessel | 0.72185217 |
| 137 | MP0000598_abnormal_liver_morphology | 0.71796809 |
| 138 | MP0009053_abnormal_anal_canal | 0.71628704 |
| 139 | MP0008469_abnormal_protein_level | 0.71271449 |
| 140 | MP0002135_abnormal_kidney_morphology | 0.69789512 |
| 141 | MP0004885_abnormal_endolymph | 0.68738333 |
| 142 | MP0010771_integument_phenotype | 0.68525119 |
| 143 | MP0005000_abnormal_immune_tolerance | 0.68008715 |
| 144 | MP0010307_abnormal_tumor_latency | 0.66682750 |
| 145 | MP0002896_abnormal_bone_mineralization | 0.66065125 |
| 146 | MP0001845_abnormal_inflammatory_respons | 0.64825546 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vertebral compression fractures (HP:0002953) | 3.60317780 |
| 2 | Premature rupture of membranes (HP:0001788) | 3.39134285 |
| 3 | Deep venous thrombosis (HP:0002625) | 3.27014191 |
| 4 | Recurrent abscess formation (HP:0002722) | 3.09534661 |
| 5 | Increased cerebral lipofuscin (HP:0011813) | 3.07567113 |
| 6 | Dysostosis multiplex (HP:0000943) | 3.03925933 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 2.97465275 |
| 8 | Xanthomatosis (HP:0000991) | 2.94276844 |
| 9 | Cerebral aneurysm (HP:0004944) | 2.88456148 |
| 10 | Abnormality of the Achilles tendon (HP:0005109) | 2.85713545 |
| 11 | Cerebral inclusion bodies (HP:0100314) | 2.81328581 |
| 12 | Mucopolysacchariduria (HP:0008155) | 2.78794005 |
| 13 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.78794005 |
| 14 | Achilles tendon contracture (HP:0001771) | 2.75650406 |
| 15 | Neurofibrillary tangles (HP:0002185) | 2.75520997 |
| 16 | Peritonitis (HP:0002586) | 2.70076716 |
| 17 | Systemic lupus erythematosus (HP:0002725) | 2.69209759 |
| 18 | Axonal loss (HP:0003447) | 2.68874681 |
| 19 | Protrusio acetabuli (HP:0003179) | 2.64978834 |
| 20 | Myocardial infarction (HP:0001658) | 2.59955491 |
| 21 | Purpura (HP:0000979) | 2.55041483 |
| 22 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.50453445 |
| 23 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.50453445 |
| 24 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.50453445 |
| 25 | Myositis (HP:0100614) | 2.50124672 |
| 26 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.46538909 |
| 27 | Complement deficiency (HP:0004431) | 2.41226655 |
| 28 | Interstitial pulmonary disease (HP:0006530) | 2.40551097 |
| 29 | Vacuolated lymphocytes (HP:0001922) | 2.38528341 |
| 30 | Orchitis (HP:0100796) | 2.37113584 |
| 31 | Polycythemia (HP:0001901) | 2.36850926 |
| 32 | Cellulitis (HP:0100658) | 2.33657139 |
| 33 | Mitral valve prolapse (HP:0001634) | 2.31557012 |
| 34 | Upper limb amyotrophy (HP:0009129) | 2.31282052 |
| 35 | Distal upper limb amyotrophy (HP:0007149) | 2.31282052 |
| 36 | Chronic obstructive pulmonary disease (HP:0006510) | 2.28519672 |
| 37 | Obstructive lung disease (HP:0006536) | 2.28519672 |
| 38 | Shallow orbits (HP:0000586) | 2.26555113 |
| 39 | Disproportionate tall stature (HP:0001519) | 2.21853619 |
| 40 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.20042508 |
| 41 | Abnormality of complement system (HP:0005339) | 2.14658658 |
| 42 | Spastic diplegia (HP:0001264) | 2.13244883 |
| 43 | Ulnar bowing (HP:0003031) | 2.12468104 |
| 44 | Genu recurvatum (HP:0002816) | 2.12365961 |
| 45 | Polygenic inheritance (HP:0010982) | 2.11089194 |
| 46 | Global brain atrophy (HP:0002283) | 2.09956751 |
| 47 | Hyperacusis (HP:0010780) | 2.09884667 |
| 48 | Loss of speech (HP:0002371) | 2.08040869 |
| 49 | Increased serum ferritin (HP:0003281) | 2.07233175 |
| 50 | Nuclear cataract (HP:0100018) | 2.06928495 |
| 51 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.06867500 |
| 52 | Spontaneous hematomas (HP:0007420) | 2.06834461 |
| 53 | Gingivitis (HP:0000230) | 2.06632633 |
| 54 | Mediastinal lymphadenopathy (HP:0100721) | 2.06150195 |
| 55 | Increased IgE level (HP:0003212) | 2.05206086 |
| 56 | Distal lower limb muscle weakness (HP:0009053) | 2.04829190 |
| 57 | Supranuclear gaze palsy (HP:0000605) | 2.02537160 |
| 58 | Hypokalemic alkalosis (HP:0001949) | 2.02377473 |
| 59 | Back pain (HP:0003418) | 2.02371735 |
| 60 | Abnormality of proline metabolism (HP:0010907) | 2.01953280 |
| 61 | Hydroxyprolinuria (HP:0003080) | 2.01953280 |
| 62 | Petechiae (HP:0000967) | 2.01825321 |
| 63 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.00591391 |
| 64 | Thin bony cortex (HP:0002753) | 1.99795688 |
| 65 | Lymphangioma (HP:0100764) | 1.99109129 |
| 66 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.97322050 |
| 67 | Osteolytic defects of the hand bones (HP:0009699) | 1.97322050 |
| 68 | Hand muscle atrophy (HP:0009130) | 1.97240491 |
| 69 | Aortic dissection (HP:0002647) | 1.95987593 |
| 70 | Increased density of long bones (HP:0006392) | 1.95070325 |
| 71 | Distal lower limb amyotrophy (HP:0008944) | 1.94706286 |
| 72 | Gout (HP:0001997) | 1.93483776 |
| 73 | Abnormality of the nasal mucosa (HP:0000433) | 1.93020664 |
| 74 | Reticulocytosis (HP:0001923) | 1.91958648 |
| 75 | J-shaped sella turcica (HP:0002680) | 1.91753387 |
| 76 | Hyperparathyroidism (HP:0000843) | 1.90945267 |
| 77 | Bone pain (HP:0002653) | 1.89544413 |
| 78 | Progressive neurologic deterioration (HP:0002344) | 1.89208186 |
| 79 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.88619224 |
| 80 | Hepatosplenomegaly (HP:0001433) | 1.88476109 |
| 81 | Increased circulating renin level (HP:0000848) | 1.87527333 |
| 82 | Peripheral demyelination (HP:0011096) | 1.86270892 |
| 83 | Hypertensive crisis (HP:0100735) | 1.85555372 |
| 84 | Diminished motivation (HP:0000745) | 1.84957267 |
| 85 | Nephritis (HP:0000123) | 1.82674009 |
| 86 | Increased CSF protein (HP:0002922) | 1.82356979 |
| 87 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.82263291 |
| 88 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.82263291 |
| 89 | Abnormality of glycolipid metabolism (HP:0010969) | 1.82263291 |
| 90 | Abnormality of iron homeostasis (HP:0011031) | 1.82098846 |
| 91 | Apathy (HP:0000741) | 1.81800129 |
| 92 | Esophageal varix (HP:0002040) | 1.81483502 |
| 93 | Neuronal loss in central nervous system (HP:0002529) | 1.80879780 |
| 94 | Increased connective tissue (HP:0009025) | 1.79863452 |
| 95 | Broad face (HP:0000283) | 1.79361271 |
| 96 | Hemorrhage of the eye (HP:0011885) | 1.79002922 |
| 97 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.78990482 |
| 98 | Glomerulonephritis (HP:0000099) | 1.78952027 |
| 99 | Pathologic fracture (HP:0002756) | 1.78797659 |
| 100 | Hematochezia (HP:0002573) | 1.77622808 |
| 101 | Abnormal platelet function (HP:0011869) | 1.77382172 |
| 102 | Impaired platelet aggregation (HP:0003540) | 1.77382172 |
| 103 | Eczematoid dermatitis (HP:0000976) | 1.77206464 |
| 104 | Abnormality of macrophages (HP:0004311) | 1.75972930 |
| 105 | Intrahepatic cholestasis (HP:0001406) | 1.75465053 |
| 106 | Focal segmental glomerulosclerosis (HP:0000097) | 1.75310898 |
| 107 | Spondylolisthesis (HP:0003302) | 1.75169555 |
| 108 | Recurrent skin infections (HP:0001581) | 1.75060174 |
| 109 | Mitral stenosis (HP:0001718) | 1.74924841 |
| 110 | Nasal polyposis (HP:0100582) | 1.74405447 |
| 111 | Flat acetabular roof (HP:0003180) | 1.74140392 |
| 112 | Sensorimotor neuropathy (HP:0007141) | 1.73898555 |
| 113 | Multiple lipomas (HP:0001012) | 1.73502181 |
| 114 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.73272499 |
| 115 | Upper motor neuron abnormality (HP:0002127) | 1.71969851 |
| 116 | Joint stiffness (HP:0001387) | 1.71861264 |
| 117 | Hypertriglyceridemia (HP:0002155) | 1.70947544 |
| 118 | Abnormal hemoglobin (HP:0011902) | 1.70665031 |
| 119 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.69114695 |
| 120 | Amyloidosis (HP:0011034) | 1.68525822 |
| 121 | Visceral angiomatosis (HP:0100761) | 1.68365677 |
| 122 | Aortic aneurysm (HP:0004942) | 1.68220566 |
| 123 | Dilatation of the ascending aorta (HP:0005111) | 1.68169115 |
| 124 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.67876599 |
| 125 | Thoracic kyphosis (HP:0002942) | 1.67655776 |
| 126 | Aneurysm (HP:0002617) | 1.67631839 |
| 127 | Asymmetric septal hypertrophy (HP:0001670) | 1.67608798 |
| 128 | Prolonged neonatal jaundice (HP:0006579) | 1.67289603 |
| 129 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.66786834 |
| 130 | Optic neuritis (HP:0100653) | 1.66748116 |
| 131 | Retrobulbar optic neuritis (HP:0100654) | 1.66748116 |
| 132 | Metabolic alkalosis (HP:0200114) | 1.66458849 |
| 133 | Cervical subluxation (HP:0003308) | 1.66029503 |
| 134 | Pseudobulbar signs (HP:0002200) | 1.65631007 |
| 135 | Blue sclerae (HP:0000592) | 1.65618580 |
| 136 | Atrophic scars (HP:0001075) | 1.65475391 |
| 137 | Epistaxis (HP:0000421) | 1.64778668 |
| 138 | Protuberant abdomen (HP:0001538) | 1.64663077 |
| 139 | Hyporeflexia of lower limbs (HP:0002600) | 1.64616360 |
| 140 | Abnormality of the thoracic spine (HP:0100711) | 1.63796657 |
| 141 | Turricephaly (HP:0000262) | 1.63298654 |
| 142 | Mesangial abnormality (HP:0001966) | 1.62994693 |
| 143 | Fragile skin (HP:0001030) | 1.62681276 |
| 144 | Glomerulosclerosis (HP:0000096) | 1.62146634 |
| 145 | Obstructive sleep apnea (HP:0002870) | 1.61540906 |
| 146 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.59684742 |
| 147 | Urticaria (HP:0001025) | 1.58007609 |
| 148 | Abnormality of purine metabolism (HP:0004352) | 1.57142201 |
| 149 | Bladder diverticulum (HP:0000015) | 1.56605740 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 5.04780185 |
| 2 | ERN1 | 3.26070524 |
| 3 | PKN2 | 3.25125168 |
| 4 | PRPF4B | 3.07811482 |
| 5 | IRAK3 | 3.05071330 |
| 6 | EEF2K | 2.97991281 |
| 7 | EPHB1 | 2.90064034 |
| 8 | SMG1 | 2.73303341 |
| 9 | LRRK2 | 2.31027896 |
| 10 | NME2 | 2.20871518 |
| 11 | BMX | 2.10155919 |
| 12 | ICK | 2.02913709 |
| 13 | RIPK4 | 1.93321889 |
| 14 | TAOK2 | 1.89203168 |
| 15 | PTK6 | 1.84465213 |
| 16 | MAP3K10 | 1.83454662 |
| 17 | RIPK1 | 1.60799816 |
| 18 | SIK1 | 1.56680121 |
| 19 | KSR2 | 1.55853762 |
| 20 | STK10 | 1.53287709 |
| 21 | IRAK4 | 1.51050037 |
| 22 | MAP4K1 | 1.45619011 |
| 23 | TTN | 1.45133361 |
| 24 | MST1R | 1.39840657 |
| 25 | FGFR4 | 1.38725284 |
| 26 | WNK4 | 1.38294885 |
| 27 | TESK2 | 1.37471821 |
| 28 | PDGFRA | 1.37458957 |
| 29 | CAMK1D | 1.36569466 |
| 30 | MAP3K14 | 1.31945845 |
| 31 | GRK6 | 1.31199881 |
| 32 | MET | 1.30356350 |
| 33 | ARAF | 1.28463607 |
| 34 | ALK | 1.28455986 |
| 35 | PAK4 | 1.25009622 |
| 36 | CAMK1G | 1.23496022 |
| 37 | BLK | 1.21216792 |
| 38 | TYRO3 | 1.20766393 |
| 39 | TBK1 | 1.20007277 |
| 40 | PAK2 | 1.19391995 |
| 41 | MAP3K9 | 1.16555997 |
| 42 | MAP3K13 | 1.15323553 |
| 43 | TGFBR2 | 1.13826331 |
| 44 | STK39 | 1.12019313 |
| 45 | PTK2 | 1.08711750 |
| 46 | CDC42BPA | 1.06693546 |
| 47 | RET | 1.06643972 |
| 48 | ILK | 1.06553924 |
| 49 | FGR | 1.05081491 |
| 50 | CSK | 1.03726713 |
| 51 | EPHA2 | 1.03683135 |
| 52 | CDK6 | 1.01839020 |
| 53 | DDR2 | 1.01279908 |
| 54 | RPS6KB2 | 1.01225974 |
| 55 | MAP3K2 | 0.99584554 |
| 56 | SCYL2 | 0.98124787 |
| 57 | TYK2 | 0.95679222 |
| 58 | FES | 0.94221578 |
| 59 | JAK3 | 0.93433905 |
| 60 | EPHB2 | 0.92356762 |
| 61 | OXSR1 | 0.88561497 |
| 62 | NTRK1 | 0.87978494 |
| 63 | SIK3 | 0.87141730 |
| 64 | TAOK1 | 0.84644030 |
| 65 | PTK2B | 0.84244968 |
| 66 | MATK | 0.82818584 |
| 67 | PAK6 | 0.82469074 |
| 68 | DYRK1B | 0.82212347 |
| 69 | MAP2K2 | 0.77903730 |
| 70 | MAP3K11 | 0.73073005 |
| 71 | MARK2 | 0.72335221 |
| 72 | RPS6KA2 | 0.72302082 |
| 73 | IRAK2 | 0.71567845 |
| 74 | PDGFRB | 0.71350661 |
| 75 | JAK2 | 0.70775155 |
| 76 | PRKD1 | 0.70767614 |
| 77 | HIPK2 | 0.70500547 |
| 78 | MAPK11 | 0.69851895 |
| 79 | GSK3A | 0.69003972 |
| 80 | ROCK2 | 0.67721018 |
| 81 | PDPK1 | 0.65841901 |
| 82 | MAP3K8 | 0.65805727 |
| 83 | HCK | 0.65109381 |
| 84 | MOS | 0.64859071 |
| 85 | MAP2K3 | 0.64823415 |
| 86 | MTOR | 0.64192628 |
| 87 | MAPKAPK3 | 0.64176064 |
| 88 | MAP3K6 | 0.62039211 |
| 89 | MAP3K3 | 0.61799960 |
| 90 | CAMKK1 | 0.60684518 |
| 91 | TESK1 | 0.60665498 |
| 92 | ABL2 | 0.60207557 |
| 93 | KIT | 0.58997259 |
| 94 | STK3 | 0.57178813 |
| 95 | PDK1 | 0.56758552 |
| 96 | JAK1 | 0.55582318 |
| 97 | LATS2 | 0.55493944 |
| 98 | MAP3K1 | 0.55065848 |
| 99 | PRKCH | 0.54407550 |
| 100 | DMPK | 0.54205174 |
| 101 | EGFR | 0.53605877 |
| 102 | RPS6KC1 | 0.53518619 |
| 103 | RPS6KL1 | 0.53518619 |
| 104 | CDK12 | 0.53306356 |
| 105 | IKBKE | 0.53099473 |
| 106 | FGFR2 | 0.52726080 |
| 107 | PIM2 | 0.52271931 |
| 108 | MAP2K1 | 0.52110679 |
| 109 | DAPK3 | 0.52028109 |
| 110 | MAPKAPK2 | 0.49283715 |
| 111 | PAK1 | 0.47643393 |
| 112 | KDR | 0.47010524 |
| 113 | ZAP70 | 0.46866401 |
| 114 | SIK2 | 0.46354963 |
| 115 | IKBKB | 0.45805180 |
| 116 | CSF1R | 0.45783057 |
| 117 | TNK2 | 0.45148417 |
| 118 | STK11 | 0.44985576 |
| 119 | PRKG2 | 0.44510074 |
| 120 | LIMK1 | 0.44040460 |
| 121 | PRKD3 | 0.42515601 |
| 122 | MAP3K7 | 0.42141459 |
| 123 | BTK | 0.41975429 |
| 124 | FYN | 0.41810316 |
| 125 | BRAF | 0.41546826 |
| 126 | FGFR3 | 0.40044179 |
| 127 | PRKD2 | 0.39922857 |
| 128 | STK38 | 0.39802990 |
| 129 | GRK7 | 0.39501004 |
| 130 | SRC | 0.38521432 |
| 131 | WNK1 | 0.37924697 |
| 132 | MAPK12 | 0.37815238 |
| 133 | LMTK2 | 0.37463337 |
| 134 | NEK9 | 0.36292549 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.76146141 |
| 2 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.84165557 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.76861363 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.76710380 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.74044180 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.70328023 |
| 7 | Lysosome_Homo sapiens_hsa04142 | 1.68314706 |
| 8 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.64030896 |
| 9 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.60993854 |
| 10 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.46374019 |
| 11 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.44465149 |
| 12 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.41831012 |
| 13 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.41110645 |
| 14 | Bile secretion_Homo sapiens_hsa04976 | 1.39827774 |
| 15 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.37183790 |
| 16 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.35294374 |
| 17 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.33525323 |
| 18 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.31098418 |
| 19 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.29883794 |
| 20 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.28576243 |
| 21 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.27538270 |
| 22 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.25156147 |
| 23 | Galactose metabolism_Homo sapiens_hsa00052 | 1.24863389 |
| 24 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.24570176 |
| 25 | Bladder cancer_Homo sapiens_hsa05219 | 1.24006681 |
| 26 | * Phagosome_Homo sapiens_hsa04145 | 1.23879159 |
| 27 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.23224663 |
| 28 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.19567881 |
| 29 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.17922457 |
| 30 | Influenza A_Homo sapiens_hsa05164 | 1.16975788 |
| 31 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.16353305 |
| 32 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.15361680 |
| 33 | Glioma_Homo sapiens_hsa05214 | 1.14393940 |
| 34 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.13782857 |
| 35 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.12262025 |
| 36 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.09403017 |
| 37 | Hepatitis B_Homo sapiens_hsa05161 | 1.09372351 |
| 38 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.09140368 |
| 39 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.08965646 |
| 40 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.08260542 |
| 41 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.07124321 |
| 42 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.07047733 |
| 43 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.06061613 |
| 44 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.05743678 |
| 45 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.05674069 |
| 46 | Focal adhesion_Homo sapiens_hsa04510 | 1.04171974 |
| 47 | Viral myocarditis_Homo sapiens_hsa05416 | 1.02180540 |
| 48 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.02083231 |
| 49 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.01801214 |
| 50 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.01696119 |
| 51 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.01089492 |
| 52 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.00763442 |
| 53 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.99703650 |
| 54 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.98493012 |
| 55 | Legionellosis_Homo sapiens_hsa05134 | 0.98211950 |
| 56 | Allograft rejection_Homo sapiens_hsa05330 | 0.97636179 |
| 57 | * Amoebiasis_Homo sapiens_hsa05146 | 0.96856157 |
| 58 | Measles_Homo sapiens_hsa05162 | 0.95906188 |
| 59 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.94050339 |
| 60 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.93649944 |
| 61 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.93071536 |
| 62 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.92689018 |
| 63 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.92108590 |
| 64 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.91030365 |
| 65 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.90959312 |
| 66 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.89139164 |
| 67 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.88934559 |
| 68 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.88177722 |
| 69 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.86659680 |
| 70 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.86642495 |
| 71 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.86271111 |
| 72 | Leishmaniasis_Homo sapiens_hsa05140 | 0.84881404 |
| 73 | * Endocytosis_Homo sapiens_hsa04144 | 0.84796301 |
| 74 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.83830760 |
| 75 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.83363992 |
| 76 | Other glycan degradation_Homo sapiens_hsa00511 | 0.82809419 |
| 77 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.82360552 |
| 78 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.82232927 |
| 79 | Histidine metabolism_Homo sapiens_hsa00340 | 0.81606053 |
| 80 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.81251336 |
| 81 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.81214000 |
| 82 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.80905597 |
| 83 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.80221749 |
| 84 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.80113969 |
| 85 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.79645079 |
| 86 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.77026017 |
| 87 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.76558790 |
| 88 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.76009065 |
| 89 | Carbon metabolism_Homo sapiens_hsa01200 | 0.75483809 |
| 90 | Thyroid cancer_Homo sapiens_hsa05216 | 0.75446218 |
| 91 | Shigellosis_Homo sapiens_hsa05131 | 0.74956061 |
| 92 | Malaria_Homo sapiens_hsa05144 | 0.74698164 |
| 93 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.73589078 |
| 94 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.71947787 |
| 95 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.71491610 |
| 96 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.71417580 |
| 97 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.70175725 |
| 98 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.70079586 |
| 99 | Insulin resistance_Homo sapiens_hsa04931 | 0.69760906 |
| 100 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.69651504 |
| 101 | Lysine degradation_Homo sapiens_hsa00310 | 0.68435546 |
| 102 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.68247559 |
| 103 | Endometrial cancer_Homo sapiens_hsa05213 | 0.67627819 |
| 104 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.66103042 |
| 105 | Pertussis_Homo sapiens_hsa05133 | 0.65010985 |
| 106 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.65003980 |
| 107 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.64543984 |
| 108 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.64326996 |
| 109 | Prion diseases_Homo sapiens_hsa05020 | 0.62970195 |
| 110 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.60821729 |
| 111 | Salmonella infection_Homo sapiens_hsa05132 | 0.60746216 |
| 112 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.60183315 |
| 113 | Platelet activation_Homo sapiens_hsa04611 | 0.59975086 |
| 114 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.58381465 |
| 115 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.58165115 |
| 116 | Hepatitis C_Homo sapiens_hsa05160 | 0.58151108 |
| 117 | HTLV-I infection_Homo sapiens_hsa05166 | 0.57994215 |
| 118 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.57744035 |
| 119 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.57398313 |
| 120 | * Tuberculosis_Homo sapiens_hsa05152 | 0.57063296 |
| 121 | Apoptosis_Homo sapiens_hsa04210 | 0.57013372 |
| 122 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.56663118 |
| 123 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.56617517 |
| 124 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.55778846 |
| 125 | Sulfur relay system_Homo sapiens_hsa04122 | 0.54687405 |
| 126 | Peroxisome_Homo sapiens_hsa04146 | 0.54396162 |
| 127 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.54205531 |
| 128 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.53307159 |
| 129 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.53078266 |
| 130 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.52630748 |
| 131 | Mineral absorption_Homo sapiens_hsa04978 | 0.52404150 |
| 132 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.52069908 |
| 133 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.50840915 |
| 134 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.50662402 |
| 135 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.49437657 |
| 136 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.49131196 |
| 137 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.48639604 |
| 138 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.48335857 |
| 139 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.48162832 |
| 140 | Asthma_Homo sapiens_hsa05310 | 0.47977344 |
| 141 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.47732618 |
| 142 | Prostate cancer_Homo sapiens_hsa05215 | 0.46811568 |
| 143 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.44571002 |

